| Akoya Biosciences is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. Spatial biology is an evolving technology that enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single-cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through its PhenoCycler and PhenoImager platforms, reagents, software and services, Co. provides solutions to perform tissue analysis and spatial phenotyping across the continuum from discovery through translational and clinical research. The AKYA average annual return since 2021 is shown above.
The Average Annual Return on the AKYA average annual return since 2021 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether AKYA average annual return since 2021 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the AKYA average annual return calculation with any dividends reinvested as applicable (on ex-dates).